Surgery after primary chemoradiotherapy in squamous cancer of the esophagus: Is the photon mightier than the sword?

Journal of Clinical Oncology

Volumn 25, Issue 10, 2007, Pages 1155-1156

  Ilson, David H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FOLLOW UP; HUMAN; PATIENT REFERRAL; PHOTON; PRIORITY JOURNAL; TREATMENT RESPONSE; ESOPHAGUS TUMOR; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY;

EID: 34247130928     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.4631     Document Type: Editorial

References (8)

1. Herskovic A, Martz LK, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
2. Bedenne L, Michel P, Bouche O, et al: Chemoradiation followed by surgery compared to chemo-radiation alone in locally advanced operable thoracic esophageal cancer: A randomized multicentric phase III trial (FFCD 9102). J Clin Oncol 25:1160-1168, 2007
3. Wobbes T, Baron B, Paillot B, et al: Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 37:470-477, 2001
4. Stahl M, Stuschke M, Lehmann N, et al: Chemoradiation with or without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317, 2005
5. Smith TJ, Ryan LM, Douglass HO, et al: Combined chemoradiotherapy versus radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Rad Oncol Phys 42:269-276, 1998
6. Van Westreenen HL, Westerterp M, Bossuyt PMM, et al: Systematic review of the performance of F-18 fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805-3812, 2004
7. Weber WA, Ott K, Becker K, et al: Prediction of response to preoperative chemotherapy in adenocarcinoma of the esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058-3065, 2001
8. Ott K, Weber WA, Lordick F, et al: Metabolic imaging predicts response, survival, and recurrence in adenocarcinoma of the gastroesophageal junction. J Clin Oncol 24:4692-4698, 2006